1. Home
  2. NTLA vs TK Comparison

NTLA vs TK Comparison

Compare NTLA & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • TK
  • Stock Information
  • Founded
  • NTLA 2014
  • TK 1973
  • Country
  • NTLA United States
  • TK Bermuda
  • Employees
  • NTLA N/A
  • TK N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • TK Marine Transportation
  • Sector
  • NTLA Health Care
  • TK Consumer Discretionary
  • Exchange
  • NTLA Nasdaq
  • TK Nasdaq
  • Market Cap
  • NTLA 686.3M
  • TK 554.2M
  • IPO Year
  • NTLA 2016
  • TK 1995
  • Fundamental
  • Price
  • NTLA $7.23
  • TK $6.64
  • Analyst Decision
  • NTLA Buy
  • TK
  • Analyst Count
  • NTLA 18
  • TK 0
  • Target Price
  • NTLA $39.44
  • TK N/A
  • AVG Volume (30 Days)
  • NTLA 3.8M
  • TK 805.8K
  • Earning Date
  • NTLA 05-08-2025
  • TK 05-08-2025
  • Dividend Yield
  • NTLA N/A
  • TK N/A
  • EPS Growth
  • NTLA N/A
  • TK N/A
  • EPS
  • NTLA N/A
  • TK 1.42
  • Revenue
  • NTLA $57,877,000.00
  • TK $1,220,374,000.00
  • Revenue This Year
  • NTLA N/A
  • TK N/A
  • Revenue Next Year
  • NTLA N/A
  • TK N/A
  • P/E Ratio
  • NTLA N/A
  • TK $4.67
  • Revenue Growth
  • NTLA 59.55
  • TK N/A
  • 52 Week Low
  • NTLA $5.90
  • TK $5.65
  • 52 Week High
  • NTLA $28.18
  • TK $9.95
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 43.76
  • TK 53.82
  • Support Level
  • NTLA $6.73
  • TK $6.23
  • Resistance Level
  • NTLA $7.76
  • TK $6.60
  • Average True Range (ATR)
  • NTLA 0.71
  • TK 0.31
  • MACD
  • NTLA 0.11
  • TK 0.04
  • Stochastic Oscillator
  • NTLA 68.91
  • TK 90.83

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About TK Teekay Corporation

Teekay Corp Ltd is engaged in providing international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services, and conventional tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

Share on Social Networks: